Home › Asthma › Texas › McKinney
Asthma clinical trials in McKinney, TX
5 studies for Asthma are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
RecruitingPhase 2
- Research Site, McKinney
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RecruitingPhase 2
- Enveda Investigative Site, McKinney
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
RecruitingPhase 3
- Research Site 33, McKinney
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
RecruitingPhase 3
- Teva Investigational Site 12096, McKinney
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RecruitingPhase 3
- Research Site, McKinney
About Asthma
Asthma causes one's airways to become sore and swollen. An attack means a person's lungs are getting less air. Learn about two types of treatment.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL12 studies
- Boston, MA11 studies
- New York City, NY11 studies
- Dallas, TX10 studies
- Oklahoma City, OK10 studies
- Durham, NC10 studies
- Washington, DC9 studies
- The Bronx, NY9 studies
- Kansas City, KS8 studies
- Houston, TX8 studies
- Pittsburgh, PA7 studies
- Charlotte, NC7 studies
Other studies in McKinney
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- COPD4 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Chronic Kidney Disease4 studies
- Interstitial Lung Diseases3 studies
- Atherosclerosis3 studies
- Graves Disease3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.